Catechol-based matrix metalloproteinase inhibitors with additional antioxidative activity.

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Structural Biology

Background:

• Matrix metalloproteinases (MMPs) and reactive oxygen species (ROS) are implicated in pathological processes like inflammation and photoaging.
• Dual-acting inhibitors targeting both MMPs and ROS offer a promising therapeutic strategy.

Purpose of the Study:

• To synthesize and evaluate novel catechol-based compounds for their MMP and antioxidant inhibitory activities.
• To elucidate the binding mode of a catechol derivative with matrix metalloproteinase-8 (MMP-8) using X-ray crystallography.

Main Methods:

• Synthesis of a series of catechol-containing chemical entities.
• In vitro assays to determine proteolytic and oxidative inhibitory activity.
• X-ray crystal structure determination of a catechol derivative complexed with MMP-8.

Main Results:

• Several synthesized catechol derivatives exhibited significant MMP and antioxidant inhibitory effects.
• X-ray crystallography revealed the binding mode of a catechol derivative with MMP-8.
• Unexpectedly, the catechol oxygens were found not to coordinate the zinc atom within the MMP-8 active site.

Conclusions:

• Catechol-based molecules can be designed as effective dual inhibitors of MMPs and ROS.
• The inhibitory mechanism does not rely on direct zinc chelation by the catechol moiety, suggesting alternative binding interactions.
• These findings open new avenues for developing novel therapeutics for diseases involving proteolytic activity and oxidative stress.